press room

releases

12/09/21 — Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere's Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

01/07/20 — AEROMICS, INC. APPOINTS JOSEPH SCHINDLER, M.D. AS CHIEF MEDICAL OFFICER

11/05/19 — AEROMICS AND SIMCERE ANNOUNCE COLLABORATION AND LICENSE AGREEMENT FOR AER-271 IN GREATER CHINA

09/09/19 — AEROMICS, INC. APPOINTS NOBEL LAUREATE PETER AGRE TO ITS BOARD OF DIRECTORS

08/16/18 — Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of Directors

07/09/18 — Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers